Syringe Market - Global Industry Analysis and Forecast (2025-2032)
The Syringe Market size was valued at USD 21.89 Bn. in 2024 and the total Global Syringe revenue is expected to grow at a CAGR of 6.5 % from 2025 to 2032, reaching nearly USD 36.23 Bn. by 2032.
Format : PDF | Report ID : SMR_1935
Syringe Market Overview
Syringes are designed for various medical purposes, such as injecting medications, drawing blood samples, administering vaccines, delivering contrast agents for imaging procedures, and flushing intravenous lines. They come in different sizes, measured in milliliters (ml) or cubic centimeters (cc), to accommodate different dosages and applications. The syringe market encompasses a wide range of products related to syringes, including disposable syringes, safety syringes, insulin syringes, and prefilled syringes, among others. The Syringe Market has grown because of technological advancements, the increasing prevalence of chronic diseases, the growing demand for vaccines and biologics, and initiatives expected to reduce needlestick injuries and cross-contamination.
The comprehensive report researches the dynamic landscape of the Syringes Market, offering detailed analysis and strategic insights for stakeholders. It investigates the nuanced trends, drivers, challenges, and opportunities in the sector. Utilizing a meticulous methodology combining primary and secondary research, the report reveals complex market dynamics, consumer behavior, regulatory frameworks, and competitive landscapes. It accurately outlines the market's current dimensions, growth patterns, size, and the nuanced trends that use significant influence. It keenly identifies the crucial factors boosting the growth of the Syringe market and highlights the increasing opportunities. Manufacturer’s purpose for Syringe market dominance through strategies like mergers, acquisitions, partnerships, and global distribution channel expansion. They invest heavily in R&D and human resources to develop their product portfolio and create significant growth in the Syringe Market.
- The top 3 exporters of Syringes are China with 82,096 shipments followed by India with 65,746 and the United States at the 3rd spot with 62,079 shipments.
To get more Insights: Request Free Sample Report
Syringe Market Dynamics
The rising geriatric population also increases the prevalence of chronic diseases.
The aging population globally is contributing to a higher demand for healthcare services, including the use of syringes for various medical procedures and drug administration. As people get older, they are more likely to develop chronic conditions. The rising incidence of chronic diseases such as diabetes, cancer, and autoimmune disorders has increased the demand for syringes used in therapeutic injections and drug delivery.
Older adults generally use healthcare services more frequently than younger people, requiring more visits to healthcare facilities, hospital stays, and medical procedures, all of which involve using syringes for various purposes such as drawing blood samples, administering medications, or delivering fluids. Many older adults prefer to receive care in the comfort of their homes or assisted living facilities. This trend has led to an increased demand for syringes that can be used for self-administration of medications or by home healthcare providers.
Growing Diabetic Patient Population to Uplift the Market for Syringes
Factors namely aging, urbanization, and changing lifestyles are contributing to the increase in long-term trends observed in diabetic patients. Individuals suffering from diabetes use insulin syringes to administer the appropriate insulin dose prescribed by healthcare professionals. Such multiple use of syringes to administer different doses per day is spurring demand for syringes. It is observed that the total number of patients requiring insulin is expected to be approximately 150 - 200 million individuals on a global level. Therefore, the use of insulin treatment to regulate blood sugar levels among the population is expected to stimulate the market growth of syringes across the globe.
The rising rate of disposable syringes Costs
Disposable syringes have a higher unit cost compared to reusable syringes, as they are designed for single use and need to be discarded after use. The costs of raw materials, manufacturing, and distribution increase, and manufacturers need to pass on these higher costs to customers, leading to higher prices for disposable syringes. This can put pricing pressure on healthcare facilities and end-users, potentially limiting adoption or causing them to seek more cost-effective alternatives. The disposal of syringes, particularly those made from non-biodegradable materials like plastics, can raise environmental concerns. This has prompted the development of more environmentally friendly and sustainable syringe options, which can be more costly. the availability of disposable syringes and the reuse of syringes in some regions due to resource constraints or lack of awareness can lead to cross-contamination and the spread of infectious diseases, hampering the syringe market.
Syringe Market Segment Analysis
Based on the Product Type, the Disposable Syringes segment held the largest market share of about 68.1% in the Syringe Market in 2024. According to the SMR analysis, the segment is expected to grow at a CAGR of 6.5 % during the forecast period and maintain its dominance till 2032. Disposable syringes are designed for single-use only, which helps prevent the spread of infections and cross-contamination. The safety factor has led to the widespread adoption of disposable syringes in healthcare settings, particularly in developing countries where safety standards are stringent.
Many countries have implemented regulations and guidelines that mandate the use of disposable syringes to ensure patient safety and prevent the transmission of infectious diseases. Disposable syringes are generally more cost-effective than reusable syringes, as they eliminate the need for sterilization and reduce the risk of contamination-related complications. Increasing health awareness among people, increasing disposable syringes, and the growing need to prevent disease spread.
- According to SMR, China exports most of its Disposable syringes to India, Pakistan, and Bahrain and is the 2nd largest exporter of Disposable syringes in the World.
- According to SMR, The top 3 exporters of Disposable syringes are India with 419 shipments followed by China with 212 and Germany at the 3rd spot with 42 shipments.
Syringe Market Regional Analysis
Asia Pacific has dominated the Syringe Market, which held the largest market share accounting for 47.10% in 2024, the region is expected to grow during the forecast period and maintain its dominance by 2032. The Asia-Pacific region has a large population, including countries like China, India, and Indonesia. This has led to an increased demand for syringes for various healthcare purposes, such as immunization programs, therapeutic injections, and blood specimen collection. The rising prevalence of chronic diseases like diabetes and cancer in the Asia-Pacific region has further boosted the demand for syringes used in therapeutic injections and other medical procedures.
Syringe manufacturers establish their production facilities and operations in the Asia-Pacific region, specifically in countries such as China, Japan, and India. This strong local presence and manufacturing capabilities greatly contribute to the region's overall dominance. In Asia-Pacific region is seeing a rise in healthcare expenditure due to improving economic conditions, growing middle-class populations, and increasing awareness about health and wellness. This has led to a higher demand for syringes.
- China's export data reveals that the number of syringe export shipments from China amounted to 82.1K. These shipments were exported by 5,058 China Exporters to 6,667 Buyers.
- China exports most of its Syringes to the United States, India, and Peru and is the largest exporter of Syringe in the World.
Syringe Market Competitive Landscape
The Syringe market is highly competitive, with many regional and local players catering to specific markets and consumer preferences. Factors such as product quality, pricing, distribution channels, and brand loyalty play a significant role in determining market dominance. The Syringe Market is always changing, with new leaders emerging and established players adjusting their strategies. One important strategy for a key company is its continuous focus on research and development (R&D) to stay at the forefront of technological advancements. To stay competitive in the global market, major players in the Syringe market have found that product launches are essential.
The key players in the Syringe market are Syringe are Becton, Dickinson and Company, B. Brawn, Medtronic Plc., Schott AG, Hindustan Syringes & Medical Devices Limited, and Gerresheimer AG.
These companies employ strategies like product/service launches, acquisitions, partnerships, regulations, and consumer demand for healthy and natural food products, driving collaborations to strengthen their market presence. The market is characterized by the government's Syringe industry's growth.
- In October 2022, Terumo Pharmaceutical Solutions (TPS) launched a ready-to-fill polymer syringe, PLAJEX 2.25 mL with Tapered Needle, designed for challenging biotech drugs with larger volumes.
- In June 2022, West Pharmaceutical Services, Inc., a company that produces innovative solutions for injectable drug administration, unveiled its new pre-fillable Daikyo Crystal Zenith 2.25mL Insert Needle Syringe System at BIO International Convention.
- In June 2022, BD (Becton, Dickinson, and Co.) and Mitsubishi Gas Chemical Co. Inc. (MCG) signed a letter of intent to discuss a partnership to explore new ways to advance pre-fillable syringe technology for biologic drug delivery.
- In August 2021, the medical syringe manufacturer Hindustan Syringes & Medical Devices Ltd (HMD) achieved a milestone of producing over 1 crore assorted-size syringes daily. Also, the strategic initiatives taken by the market players are expected to propel the growth of the market.
- In April 2021, West Pharmaceutical Services, Inc. extended its partnership with Venus Remedies Ltd. to deliver the Nova Guard SA Pro safety system, aiding biopharmaceutical manufacturers in packaging drugs in pre-fillable syringes with needle stick prevention features.
Syringe Market Scope |
|
Market Size in 2024 |
USD 21.89 Bn. |
Market Size in 2032 |
USD 36.23 Bn. |
CAGR (2025-2032) |
6.5 % |
Historic Data |
2019-2024 |
Base Year |
2024 |
Forecast Period |
2025-2032 |
Segment |
by Product Type Reusable Syringes Disposable Syringes Conventional Syringes Safety Syringes Prefillable Syringes |
by material Glass Syringes Plastic Syringes |
|
by Application Immunization Therapeutic Injections Insulin Injections Antiviral Injections Others |
|
By End Users Hospitals Diagnostic laboratories Clinics Ambulatory Surgical Centers Others |
|
Regional Scope |
North America(United States), Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Austria, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America |
Key Player in the Syringe Market
- Becton, Dickinson and Company (BD)(New Jersey)
- B. Braun Melsungen AG (Germany)
- Terumo Corporation(Japan)
- Smiths Medical (U.S.)
- Nipro Corporation (Japan)
- Henke Sass Wolf GmbH (Germany)
- SCHOTT AG Germany)
- Cardinal Health, Inc. (U.S.)
- Gerresheimer AG (Germany)
- Medtronic plc (Ireland)
- Retractable Technologies, Inc.(Texas)
- Baxter International Inc.(U.S.)
- SOCOREX ISBA SA (Switzerland)
- Vita Needle Company (U.S.)
- Hindustan Syringes & Medical Devices Ltd. (India)
- Nipro PharmaPackaging (Japan)
- Ronco Group (Poland)
- Datwyler Holding Inc. (Switzerland)
- Catalent, Inc.(U.S.)
- XX Ltd
Frequently Asked Questions
Asia Pacific is expected to hold the highest share of the Syringe Market.
The Syringe Market size was valued at USD 21.89 Billion in 2024 reaching nearly USD 36.23 Billion in 2032.
Continuous technological advancements in syringe design, materials, and functionality create opportunities for innovative products that can improve patient safety, enhance drug delivery, and offer better user practices.
The segments covered in the Syringe Market report are based on Source, Type, Feature, Application form, and Distribution Channels.
1. Syringe Market: Research Methodology
2. Syringe Market: Executive Summary
3. Syringe Market: Competitive Landscape
3.1. Stellar Competition Matrix
3.2. Competitive Landscape
3.3. Key Players Benchmarking
3.4. Market Structure
3.4.1. Market Leaders
3.4.2. Market Followers
3.4.3. Emerging Players
3.5. Consolidation of the Market
3.6. Global Import-Export Analysis
4. Syringe Market: Dynamics
4.1. Market Driver
4.2. Market Trends
4.3. Market Restraints
4.4. Market Opportunities
4.5. Market Challenges
4.6. PORTER’s Five Forces Analysis
4.7. PESTLE Analysis
4.8. Strategies for New Entrants to Penetrate the Market
4.9. Regulatory Landscape by Region
4.9.1. North America
4.9.2. Europe
4.9.3. Asia Pacific
4.9.4. Middle East and Africa
4.9.5. South America
5. Syringe Market Size and Forecast by Segments (by Value in USD Billion )
5.1. Syringe Market Size and Forecast, by Product Type (2024-2032)
5.1.1. Reusable Syringes
5.1.2. Disposable Syringes
5.1.2.1. Conventional Syringes
5.1.2.2. Safety Syringes
5.1.2.3. Prefillable Syringes
5.2. Syringe Market Size and Forecast, by Material (2024-2032)
5.2.1. Glass Syringes
5.2.2. Plastic Syringes
5.3. Syringe Market Size and Forecast, by Application (2024-2032)
5.3.1. Immunization
5.3.2. Therapeutic Injections
5.3.3. Insulin Injections
5.3.4. Antiviral Injections
5.3.5. Surgery
5.3.6. Others
5.4. Syringe Market Size and Forecast, by End Users (2024-2032)
5.4.1. Hospitals
5.4.2. Diagnostic Laboratories
5.4.3. Clinics
5.4.4. Ambulatory Surgical Centers
5.4.5. Others
5.5. Syringe Market Size and Forecast, by Region (2024-2032)
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Middle East and Africa
5.5.5. South America
6. North America Syringe Market Size and Forecast (by Value in USD Billion )
6.1. North America Syringe Market Size and Forecast, by Product Type (2024-2032)
6.1.1. Reusable Syringes
6.1.2. Disposable Syringes
6.1.2.1. Conventional Syringes
6.1.2.2. Safety Syringes
6.1.2.3. Prefillable Syringes
6.2. North America Syringe Market Size and Forecast, by Material (2024-2032)
6.2.1. Glass Syringes
6.2.2. Plastic Syringes
6.3. North America Syringe Market Size and Forecast, by Application (2024-2032)
6.3.1. Immunization
6.3.2. Therapeutic Injections
6.3.3. Insulin Injections
6.3.4. Antiviral Injections
6.3.5. Surgery
6.3.6. Others
6.4. Syringe Market Size and Forecast, by End Users (2024-2032)
6.4.1. Hospitals
6.4.2. Diagnostic Laboratories
6.4.3. Clinics
6.4.4. Ambulatory Surgical Centers
6.4.5. Others
6.5. North America Syringe Market Size and Forecast, by Country (2024-2032)
6.5.1. United States
6.5.2. Canada
6.5.3. Mexico
7. Europe Syringe Market Size and Forecast (by Value in USD Billion )
7.1. Europe Syringe Market Size and Forecast, by Product Type (2024-2032)
7.1.1. Reusable Syringes
7.1.2. Disposable Syringes
7.1.2.1. Conventional Syringes
7.1.2.2. Safety Syringes
7.1.2.3. Prefillable Syringes
7.2. Europe Syringe Market Size and Forecast, by Material (2024-2032)
7.2.1. Glass Syringes
7.2.2. Plastic Syringes
7.3. Europe Syringe Market Size and Forecast, by Application (2024-2032)
7.3.1. Immunization
7.3.2. Therapeutic Injections
7.3.3. Insulin Injections
7.3.4. Antiviral Injections
7.3.5. Surgery
7.3.6. Others
7.4. Syringe Market Size and Forecast, by End Users (2024-2032)
7.4.1. Hospitals
7.4.2. Diagnostic Laboratories
7.4.3. Clinics
7.4.4. Ambulatory Surgical Centers
7.4.5. Others
7.5. Europe Syringe Market Size and Forecast, by Country (2024-2032)
7.5.1. UK
7.5.2. France
7.5.3. Germany
7.5.4. Italy
7.5.5. Spain
7.5.6. Sweden
7.5.7. Austria
7.5.8. Rest of Europe
8. Asia Pacific Syringe Market Size and Forecast (by Value in USD Billion )
8.1. Asia Pacific Syringe Market Size and Forecast, by Product Type (2024-2032)
8.1.1. Reusable Syringes
8.1.2. Disposable Syringes
8.1.2.1. Conventional Syringes
8.1.2.2. Safety Syringes
8.1.2.3. Prefillable Syringes
8.2. Asia Pacific Syringe Market Size and Forecast, by Material (2024-2032)
8.2.1. Glass Syringes
8.2.2. Plastic Syringes
8.3. Asia Pacific Syringe Market Size and Forecast, by Application (2024-2032)
8.3.1. Immunization
8.3.2. Therapeutic Injections
8.3.3. Insulin Injections
8.3.4. Antiviral Injections
8.3.5. Surgery
8.3.6. Others
8.4. Syringe Market Size and Forecast, by End Users (2024-2032)
8.4.1. Hospitals
8.4.2. Diagnostic Laboratories
8.4.3. Clinics
8.4.4. Ambulatory Surgical Centers
8.4.5. Others
8.5. Asia Pacific Syringe Market Size and Forecast, by Country (2024-2032)
8.5.1. China
8.5.2. S Korea
8.5.3. Japan
8.5.4. India
8.5.5. Australia
8.5.6. Indonesia
8.5.7. Malaysia
8.5.8. Vietnam
8.5.9. Taiwan
8.5.10. Bangladesh
8.5.11. Pakistan
8.5.12. Rest of Asia Pacific
9. Middle East and Africa Syringe Market Size and Forecast (by Value in USD Billion )
9.1. Middle East and Africa Syringe Market Size and Forecast, by Product Type (2024-2032)
9.1.1. Reusable Syringes
9.1.2. Disposable Syringes
9.1.2.1. Conventional Syringes
9.1.2.2. Safety Syringes
9.1.2.3. Prefillable Syringes
9.2. Middle East and Africa Syringe Market Size and Forecast, by Material (2024-2032)
9.2.1. Glass Syringes
9.2.2. Plastic Syringes
9.3. Middle East and Africa Syringe Market Size and Forecast, by Application (2024-2032)
9.3.1. Immunization
9.3.2. Therapeutic Injections
9.3.3. Insulin Injections
9.3.4. Antiviral Injections
9.3.5. Surgery
9.3.6. Others
9.4. Syringe Market Size and Forecast, by End Users (2024-2032)
9.4.1. Hospitals
9.4.2. Diagnostic Laboratories
9.4.3. Clinics
9.4.4. Ambulatory Surgical Centers
9.4.5. Others
9.5. Middle East and Africa Single-Use Filtration Assembly Market Size and Forecast, by Country (2024-2032)
9.5.1. South Africa
9.5.2. GCC
9.5.3. Egypt
9.5.4. Nigeria
9.5.5. Rest of ME&A
10. South America Syringe Market Size and Forecast (by Value in USD Billion )
10.1. South America Syringe Market Size and Forecast, by Product Type (2024-2032)
10.1.1. Reusable Syringes
10.1.2. Disposable Syringes
10.1.2.1. Conventional Syringes
10.1.2.2. Safety Syringes
10.1.2.3. Prefillable Syringes
10.2. South America Syringe Market Size and Forecast, by Material (2024-2032)
10.2.1. Glass Syringes
10.2.2. Plastic Syringes
10.3. South America Syringe Market Size and Forecast, by Application (2024-2032)
10.3.1. Immunization
10.3.2. Therapeutic Injections
10.3.3. Insulin Injections
10.3.4. Antiviral Injections
10.3.5. Surgery
10.3.6. Others
10.4. Syringe Market Size and Forecast, by End Users (2024-2032)
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Clinics
10.4.4. Ambulatory Surgical Centers
10.4.5. Others
10.5. South America Syringe Market Size and Forecast, by Country (2024-2032)
10.5.1. Brazil
10.5.2. Argentina
10.5.3. Rest of South America
11. Company Profile: Key players
11.1. Bayer (Germany)
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Business Portfolio
11.1.4. SWOT Analysis
11.1.5. Business Strategy
11.1.6. Recent Developments
11.2. Becton, Dickinson and Company (BD)(New Jersey)
11.3. B. Braun Melsungen AG (Germany)
11.4. Terumo Corporation(Japan)
11.5. Smith’s Medical (U.S.)
11.6. Nipro Corporation (Japan)
11.7. Henke Sass Wolf GmbH (Germany)
11.8. SCHOTT AG Germany)
11.9. Gerresheimer AG (Germany)
11.10. Medtronic plc. (Ireland)
11.11. Retractable Technologies, Inc.(Texas)
11.12. Baxter International Inc.(U.S.)
11.13. SOCOREX ISBA SA (Switzerland)
11.14. Vita Needle Company (U.S.)
11.15. Hindustan Syringes & Medical Devices Ltd. (India)
11.16. Nipro Pharma Packaging (Japan)
11.17. Ronco Group (Poland)
11.18. Datwyler Holding Inc. (Switzerland)
11.19. Catalent, Inc.(U.S.)
12. Key Findings
13. Industry Recommendations